Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02013804 |
| Title | A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | MedImmune LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | New Haven | Connecticut | 06511 | United States | Details | |
| Research Site | Detroit | Michigan | 48201 | United States | Details | |
| Research Site | The Bronx | New York | 10461 | United States | Details | |
| Research Site | Portland | Oregon | 97213 | United States | Details | |
| Research Site | Nashville | Tennessee | 37203 | United States | Details | |
| Research Site | Houston | Texas | 77030 | United States | Details |